Because of that difference, research protocols schedule them differently: BPC-157 features far more frequently, while TB-500 appears on a much less frequent schedule, often with an initial higher-frequency phase followed by a lower-frequency one
And I dont know, we work with a lot of surgeons, we work with a lot of really important people, and say someones not competing, but if something goes wrong, and it comes back that you recommended or you were like, Yeah, try these injectable peptides that are not FDA regulated, and something goes wrong with the surgery or whatever they have, I just dont want that heat
PMCID: PMC10748240
Is BPC-157 authorised as a UK medicine
After an initial loading phase of six injections over two weeks (or more frequently if neurological symptoms are present), maintenance injections are given every two to three months for life to prevent deficiency recurrence